Jeff Yass’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,700
| Closed | -$942K | – | 14137 |
|
|
2021
Q2 | $942K | Buy |
5,700
+1,000
| +21% | +$167K | ﹤0.01% | 7937 |
|
|
2021
Q1 | $721K | Buy |
4,700
+100
| +2% | +$13.6K | ﹤0.01% | 8584 |
|
|
2020
Q4 | $577K | Sell |
4,600
-41,200
| -90% | -$4.61M | ﹤0.01% | 7971 |
|
|
2020
Q3 | $4.65M | Buy |
45,800
+2,000
| +5% | +$204K | ﹤0.01% | 3147 |
|
|
2020
Q2 | $4.26M | Buy |
43,800
+6,100
| +16% | +$568K | ﹤0.01% | 3236 |
|
|
2020
Q1 | $3.13M | Buy |
37,700
+29,400
| +354% | +$2.87M | ﹤0.01% | 3221 |
|
|
2019
Q4 | $923K | Sell |
8,300
-44,900
| -84% | -$4.62M | ﹤0.01% | 5684 |
|
|
2019
Q3 | $5.28M | Buy |
53,200
+14,600
| +38% | +$1.45M | ﹤0.01% | 2653 |
|
|
2019
Q2 | $3.83M | Sell |
38,600
-21,300
| -36% | -$2.03M | ﹤0.01% | 3089 |
|
|
2019
Q1 | $6.61M | Buy |
59,900
+40,600
| +210% | +$4.24M | ﹤0.01% | 2146 |
|
|
2018
Q4 | $1.77M | Sell |
19,300
-14,800
| -43% | -$1.5M | ﹤0.01% | 3699 |
|
|
2018
Q3 | $3.76M | Buy |
34,100
+24,300
| +248% | +$2.53M | ﹤0.01% | 3051 |
|
|
2018
Q2 | $915K | Buy |
9,800
+4,700
| +92% | +$405K | ﹤0.01% | 5539 |
|
|
2018
Q1 | $423K | Sell |
5,100
-4,200
| -45% | -$373K | ﹤0.01% | 6973 |
|
|
2017
Q4 | $847K | Sell |
9,300
-3,800
| -29% | -$316K | ﹤0.01% | 5569 |
|
|
2017
Q3 | $998K | Sell |
13,100
-3,200
| -20% | -$242K | ﹤0.01% | 5271 |
|
|
2017
Q2 | $1.22M | Buy |
16,300
+6,300
| +63% | +$437K | ﹤0.01% | 4851 |
|
|
2017
Q1 | $652K | Buy |
10,000
+2,300
| +30% | +$135K | ﹤0.01% | 5992 |
|
|
2016
Q4 | $424K | Sell |
7,700
-19,200
| -71% | -$1.05M | ﹤0.01% | 7321 |
|
|
2016
Q3 | $1.52M | Buy |
26,900
+12,000
| +81% | +$588K | ﹤0.01% | 4013 |
|
|
2016
Q2 | $622K | Buy |
14,900
+6,300
| +73% | +$290K | ﹤0.01% | 5762 |
|
|
2016
Q1 | $368K | Buy |
+8,600
| New | +$363K | ﹤0.01% | 6918 |
|
|
2015
Q4 | – | Sell |
-7,400
| Closed | -$287K | – | 10205 |
|
|
2015
Q3 | $287K | Sell |
7,400
-7,400
| -50% | -$296K | ﹤0.01% | 8113 |
|
|
2015
Q2 | $538K | Buy |
14,800
+2,900
| +24% | +$91.7K | ﹤0.01% | 7495 |
|
|
2015
Q1 | $343K | Buy |
+11,900
| New | +$332K | ﹤0.01% | 7733 |
|
Other funds holding PRAH
Jeff Yass's PRAH Position: Q3 2021 in Review
Jeff Yass sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 622,837 shares — an estimated $103M sold.
Jeff Yass first reported a position in PRAH in Q4 2014 and held it in 18 quarters. The position peaked at $103M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Jeff Yass reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Jeff Yass sold 622,837 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $103M.
- Jeff Yass first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 18 quarters.
- Jeff Yass's PRA Health Sciences, Inc. position peaked at $103M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.